Sun Kang sold $1.0M of AMPX

Sun Kang sold 67,796 shares of Amprius Technologies, Inc. (AMPX) at $14.79 ($1.00M total) on 2026-05-21.

Original reporting
SEC EDGAR · Sun Kang
Published May 26, 2026, 11:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 11:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMPX
Bearish
medium confidence
Mentioned
$AMPX
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMPXBearishMed
01

Why it matters

Insider selling can influence short-term sentiment, especially when not clearly tied to a 10b5-1 plan, but it typically lacks the informational weight of earnings, guidance, or deal news.

02

Market read

Traders may watch for incremental selling pressure or interpret the sale as a mild negative signal, but fundamentals are unchanged by this disclosure alone.

03

What to watch

No 10b5-1 plan is stated, but the article provides no context on prior grants, vesting schedules, or whether the director’s overall stake is part of a planned disposal cadence.

Relevance 8/10Timing: Immediate (filed 2026-05-26; transaction dated 2026-05-21).

Background

The article is an SEC Form 4 insider transaction disclosure for Amprius Technologies, Inc. (AMPX).

Company-level read

Ticker impact

$AMPXBearishMedium confidence
Context

Sun Kang, a director of Amprius Technologies, filed an open-market sale of 67,796 shares worth about $1.0M on 2026-05-21.

Expected impact

Near-term bias to the downside or volatility around the filing; limited follow-through absent other news.

Evidence & confidence

The filing is a Form 4 insider sale with no stated 10b5-1 plan, which can be interpreted as discretionary selling, but insider sales are often non-informational without accompanying operational/financial developments.

Market effects

Limited read-across to the broader battery/energy-storage supply chain; this is company-specific insider activity.

No clear regional spillover indicated by the filing alone.

No direct global catalyst; relevance is primarily sentiment/positioning for AMPX.

Counterpoint

The sale may be routine liquidity management (e.g., taxes or diversification) and does not necessarily reflect negative company outlook.

Key entities

  • Amprius Technologies, Inc.

    AMPX; director Sun Kang reported an open-market sale of 67,796 shares worth ~$1.0M.

  • Sun Kang

    Director of AMPX; sold shares on 2026-05-21; Form 4 filed 2026-05-26.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMPXMedAI 8/10

Amprius (AMPX) Q3 2026 Earnings Call Transcript

Amprius reported Q3 2026 revenue of $39.1M, up 83% YoY, raising its full-year target to $145M. The company introduced SiCore 500 cells for aviation and secured a $75M U.S. defense contract. Amprius expanded into maritime vehicles and partnered with U.S. manufacturers for NDAA-compliant production.

$AMPXMedAI 8/10

Amprius Technologies Q3 Earnings Call Highlights

Amprius reported a Q3 net loss of $3.5M, with adjusted EBITDA at -$1M. The company maintained its full-year gross margin forecast of 28% and expects Q4 sales of $43.3M. Amprius is expanding manufacturing to meet demand, with a $75M contract for a U.S. battery production line. It also introduced new products for aviation and deep-sea applications, ending Q3 with $60.7M in cash.

$AMPXHigh

Amprius Technologies falls 7% on third quarter earnings miss

Amprius Technologies (NYSE:AMPX) reported Q3 earnings missing estimates with a loss of $0.02 per share, though revenue of $39.1M beat expectations. Shares fell 7.7% after-hours. The company raised its full-year 2026 revenue outlook to $145M, above analyst forecasts. Gross profit rose 217% YoY to $10.5M, with gross margin improving to 27%. Amprius secured a $75M U.S. Department of War contract and introduced a new battery cell.

$AMPXMed

Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent

Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights • Q3 2026 revenue increased 83% year-over-year to $39.1 million • Net loss of $3.5 million, a 10% year-over-year improvement • Increasing 2026 revenue outlook to $145 mil

$AMPXHigh

AMPX Stock Jumps As Defense Deals Supercharge Growth Story

Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.